Data-Driven Trends In Predetermined Change Control Plans
Data-driven trends show increased FDA authorization of PCCPs, enhancing SaMD compliance and postmarket change controls.
top of page
Yu Zhao
6月28日讀畢需時 1 分鐘
Yu Zhao Joins Orthogonal Panel on Accelerating AI Algorithm Updates with PCCP
Yu Zhao joined a panel hosted by Orthogonal discussing how PCCP accelerates AI algorithm updates, FDA policies, and best practices.
3 次查看0 則留言
Yu Zhao
2023年10月13日讀畢需時 6 分鐘
Part III: SaMD PCCP Implementation Beyond AIML: Considerations & Challenges
This article provides tips and practical considerations for PCCP implementation.
4 次查看0 則留言
Yu Zhao
2023年10月10日讀畢需時 11 分鐘
Part II: Deciphering New US Laws Around Predetermined Change Control Plan
This article deciphers the new U.S. laws around Predetermined Change Control Plans (PCCP).
2 次查看0 則留言
Yu Zhao
2023年10月4日讀畢需時 5 分鐘
Part I: Medical Device Postmarket Change Controls and FDA 510(k) Software Modification Guidance
FDA's guidance on postmarket change controls for 510(k) software modifications ensures SaMD changes maintain safety and compliance.
3 次查看0 則留言
Yu Zhao
2022年5月3日讀畢需時 1 分鐘
Yu Zhao Co-Hosts Panel on Global AI-Based Medical Device Regulations at MedCon 2022
Yu Zhao co-hosted a panel on AI-based medical device regulations at MedCon 2022, discussing EU AI Act and U.S. FDA framework for SaMD.
1 次查看0 則留言
bottom of page